Alpine Immune Sciences to Participate in Upcoming Virtual Healthcare Conferences

Rhea-AI Summary

Alpine Immune Sciences (NASDAQ:ALPN) has announced its participation in three upcoming virtual healthcare conferences. The events include the Cowen 41st Annual Virtual Health Care Conference on March 1, 2021, featuring a Novel IO Panel at 10:20 a.m. ET; the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, with an on-demand company presentation starting at 7:00 a.m. ET; and the Oppenheimer 31st Annual Virtual Healthcare Conference on March 17, 2021, at 1:50 p.m. ET. Webcasts of the presentations will be available for 90 days online.

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will participate at the Cowen 41st Annual Virtual Health Care Conference, H.C. Wainwright Global Life Sciences Conference, and Oppenheimer 31st Annual Virtual Healthcare Conference.

Cowen 41st Annual Virtual Health Care Conference
Date: Monday, March 1, 2021
Time: 10:20 a.m. ET/7:20 a.m. PT
Event: Novel IO Panel

H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time: Available on demand beginning 7:00 a.m. ET/4:00 a.m. PT
Event: Company Presentation

Oppenheimer 31st Annual Virtual Healthcare Conference
Date: Wednesday, March 17, 2021
Time: 1:50 p.m. ET/10:50 a.m. PT
Event: Company Presentation

A webcast of the H.C. Wainwright and Oppenheimer presentations will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the presentations will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is creating first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

“Secreted Immunomodulatory Proteins,” “SIP,” “Transmembrane Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005621/en/

FAQ

When is Alpine Immune Sciences participating in the Cowen Virtual Health Care Conference?

Alpine Immune Sciences will participate in the Cowen 41st Annual Virtual Health Care Conference on March 1, 2021, at 10:20 a.m. ET.

What events is Alpine Immune Sciences attending in March 2021?

Alpine Immune Sciences will attend the Cowen 41st Annual Virtual Health Care Conference, H.C. Wainwright Global Life Sciences Conference, and Oppenheimer 31st Annual Virtual Healthcare Conference in March 2021.

What time is the H.C. Wainwright Global Life Sciences Conference for Alpine Immune Sciences?

The H.C. Wainwright Global Life Sciences Conference will feature Alpine Immune Sciences on March 9, 2021, available on demand starting at 7:00 a.m. ET.

When will the Oppenheimer Virtual Healthcare Conference presentation occur?

Alpine Immune Sciences' presentation at the Oppenheimer 31st Annual Virtual Healthcare Conference will take place on March 17, 2021, at 1:50 p.m. ET.

Where can I find the webcasts of Alpine Immune Sciences' presentations?

The webcasts of Alpine Immune Sciences' presentations will be available in the investor relations section of their website for 90 days following the events.